COMPANY

AstraZeneca AB

AstraZeneca AB: marketing authorisation holder, trial sponsor for Exenatide, Glucagon, Goserelin, Semaglutide, Triptorelin, as stated by public registers.

Also written as: Astrazeneca AB.

MARKETING AUTHORISATION HOLDER

Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).

Exenatide	Bydureon (EMEA/H/C/002020), Withdrawn Regulator EMA
Exenatide	Byetta (EMEA/H/C/000698), Withdrawn Regulator EMA

TRIAL SPONSOR

Sponsors registered clinical trials of the peptide.

Glucagon	2 registered trials Trial register EU CTIS
Goserelin	4 registered trials Trial register EU CTIS
Semaglutide	1 registered trial Trial register EU CTIS
Triptorelin	2 registered trials Trial register EU CTIS

What a register states, not an endorsement or an accusation by this site. All companies.

WEEKLY

Register Watch, weekly

New trials, approvals and enforcement actions. One email a week.